Qingwen Lyu

1PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 08, 2020
EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma.

Weimei Huang, Anqi Lin, Peng Luo

Pageof 1

Frequent Collaborators

1 joint publications

Weimei Huang

1 joint publications

Linlang Guo

1 joint publications

Jian Zhang